INFI - Infinity Pharmaceuticals GAAP EPS of -$0.50 misses by $0.11 revenue of $2.59M misses by $11.31M
2023-03-28 16:48:35 ET
- Infinity Pharmaceuticals press release ( NASDAQ: INFI ): FY GAAP EPS of -$0.50 misses by $0.11 .
- Revenue of $2.59M (+39.2% Y/Y) misses by $11.31M .
- At December 31, 2022, Infinity had total cash and cash equivalents of $38.3 million, compared to $80.7 million at December 31, 2021.
- Shares +3.84% .
For further details see:
Infinity Pharmaceuticals GAAP EPS of -$0.50 misses by $0.11, revenue of $2.59M misses by $11.31M